DeMuth Peter
Elicio Therapeutics, Inc. · Chief Scientific Officer
DeMuth Peter is listed in public filings as officer: Chief Scientific Officer. This DeMuth Peter insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Elicio Therapeutics, Inc. (ELTX). Investors use DeMuth Peter's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $337k41.6k shares | Grant / ExerciseFeb 2, 2026 | $337.0K41.6k shares | $8.10 | -- | |
| --21.5k shares | Grant / ExerciseFeb 2, 2026 | Disclosure amount unavailable20.8k shares | -- | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $0362 shares | Grant / ExerciseDec 9, 2025 | $1.6K362 shares | $4.41 | -- | |
| $396k44.4k shares | Grant / ExerciseFeb 3, 2025 | $396.0K44.4k shares | $8.92 | -- | |
| $0381 shares | Grant / ExerciseDec 16, 2024 | $1.7K381 shares | $4.41 | -- | |
| $150k29.8k shares | Grant / ExerciseSep 30, 2024 | $149.9K29.8k shares | $5.03 | -- |